Quick Answer
GUIDED THERAPEUTICS INC reported Net Income Loss of -$3.20 million for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -32.2% in Net Income Loss from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Net Income Loss has declined by 12.3%.
- Historical annual values: Fiscal year 2025: -$3.20 million | Fiscal year 2024: -$2.42 million | Fiscal year 2023: -$3.49 million | Fiscal year 2022: -$4.34 million | Fiscal year 2021: -$2.07 million | Fiscal year 2020: -$279.0 thousand | Fiscal year 2019: -$1.92 million | Fiscal year 2018: $1.02 million | Fiscal year 2017: -$10.70 million | Fiscal year 2016: -$3.97 million | Fiscal year 2015: -$6.90 million | Fiscal year 2014: -$9.88 million | Fiscal year 2013: -$7.22 million | Fiscal year 2012: -$4.35 million | Fiscal year 2011: -$6.64 million | Fiscal year 2010: -$2.85 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: